T. Rowe Price Associates’s Radius Health, Inc. RDUS Stock Holding History

T. Rowe Price Associates’s Portfolio RDUS Stock Details RDUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,631,498	Closed	-$14.4M	–	3032
2022 Q1	$14.4M	Buy	1,631,498 +37,451	+2%	+$284K	﹤0.01%	1311
2021 Q4	$11M	Sell	1,594,047 -6,097,624	-79%	-$89.5M	﹤0.01%	1396
2021 Q3	$95.5M	Sell	7,691,671 -278,505	-3%	-$4.01M	0.01%	785
2021 Q2	$145M	Buy	7,970,176 +15,891	+0.2%	+$316K	0.01%	658
2021 Q1	$166M	Buy	7,954,285 +1,604,837	+25%	+$33.8M	0.02%	607
2020 Q4	$113M	Buy	6,349,448 +1,492,437	+31%	+$22.4M	0.01%	690
2020 Q3	$55.1M	Sell	4,857,011 -603,502	-11%	-$7.46M	0.01%	832
2020 Q2	$74.4M	Sell	5,460,513 -45,120	-0.8%	-$621K	0.01%	718
2020 Q1	$71.6M	Sell	5,505,633 -334,661	-6%	-$5.97M	0.01%	672
2019 Q4	$118M	Buy	5,840,294 +1,240,621	+27%	+$30.1M	0.02%	614
2019 Q3	$118M	Buy	4,599,673 +724,360	+19%	+$17.8M	0.02%	579
2019 Q2	$94.4M	Buy	3,875,313 +1,314,899	+51%	+$28.7M	0.01%	663
2019 Q1	$51.1M	Buy	2,560,414 +22,283	+0.9%	+$406K	0.01%	872
2018 Q4	$41.9M	Buy	2,538,131 +19,958	+0.8%	+$336K	0.01%	887
2018 Q3	$44.8M	Sell	2,518,173 -1,634,754	-39%	-$37M	0.01%	954
2018 Q2	$122M	Sell	4,152,927 -940,350	-18%	-$29.7M	0.02%	607
2018 Q1	$183M	Sell	5,093,277 -1,161,919	-19%	-$42M	0.03%	485
2017 Q4	$199M	Sell	6,255,196 -872,637	-12%	-$27.4M	0.03%	464
2017 Q3	$275M	Buy	7,127,833 +76,975	+1%	+$3.02M	0.05%	381
2017 Q2	$319M	Buy	7,050,858 +3,079,397	+78%	+$118M	0.06%	333
2017 Q1	$153M	Buy	3,971,461 +891,630	+29%	+$37.4M	0.03%	491
2016 Q4	$117M	Buy	3,079,831 +2,027,813	+193%	+$96.5M	0.02%	553
2016 Q3	$56.9M	Buy	1,052,018 +463,447	+79%	+$23.6M	0.01%	767
2016 Q2	$21.6M	Buy	588,571 +574,011	+3,942%	+$20.3M	﹤0.01%	1075
2016 Q1	$458K	Buy	14,560 +7,512	+107%	+$260K	﹤0.01%	2013
2015 Q4	$434K	Buy	+7,048	New	+$445K	﹤0.01%	2018